Physician profile
Herbert B Master
NPI 1225009764
$1,013.59
in general payments reported to CMS, 2019-2025
21 companies · $14.05 in 2025
The $14.05 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $849 · 2020: $89.30 · 2021: $22.15 · 2024: $39.10 · 2025: $14.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $53.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $53.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $180.26 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $120.95 | 2019-2020 | |
| Edwards Lifesciences Corporation | $120.70 | 2019 | |
| Akcea Therapeutics, INC. | $80.85 | 2019-2020 | |
| Amgen INC. | $73.00 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $72.52 | 2019 | |
| Atricure, INC. | $66.53 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $52.85 | 2019 | |
| Philips North America LLC | $39.10 | 2024 | (5044) Mcot |
| Abiomed | $34.22 | 2019-2021 | |
| Arbor Pharmaceuticals, INC. | $27.26 | 2019 | |
| Lundbeck LLC | $24.27 | 2019 | |
| Preventice Services, LLC | $20.82 | 2019 | |
| Irhythm Technologies, INC. | $14.29 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $14.12 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cycle Pharmaceuticals INC | $14.05 | 2025 | Phyrago |
| Pfizer INC. | $14.02 | 2019 | |
| Amarin Pharma, INC. | $11.84 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $11.38 | 2019 | |
| Astellas Pharma US INC | $11.37 | 2020 | |
| Bardy Diagnostics, INC. | $9.19 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Herbert Master listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.